Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. (2021)
Attributed to:
Interrogating disease clusters, multimorbidity and adverse outcomes in chronic kidney disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00799-6
PubMed Identifier: 34274064
Publication URI: http://europepmc.org/abstract/MED/34274064
Type: Journal Article/Review
Volume: 398
Parent Publication: Lancet (London, England)
Issue: 10296
ISSN: 0140-6736